These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38612817)

  • 1. In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide.
    Hochrainer N; Serafin P; D'Ingiullo S; Mollica A; Granica S; Brytan M; Kleczkowska P; Spetea M
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking.
    Dumitrascuta M; Bermudez M; Trovato O; De Neve J; Ballet S; Wolber G; Spetea M
    Molecules; 2021 May; 26(11):. PubMed ID: 34071603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
    Negri L; Lattanzi R; Melchiorri P
    Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
    Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
    Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid/Dopamine Receptor Binding Studies, NMR and Molecular Dynamics Simulation of LENART01 Chimera, an Opioid-Bombesin-like Peptide.
    Serafin P; Szeleszczuk Ł; Zhukov I; Szűcs E; Gombos D; Stefanucci A; Mollica A; Pisklak DM; Kleczkowska P
    Molecules; 2024 Jan; 29(1):. PubMed ID: 38202853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand.
    Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
    Life Sci; 2012 Jun; 90(25-26):957-61. PubMed ID: 22580287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice.
    Lowery JJ; Raymond TJ; Giuvelis D; Bidlack JM; Polt R; Bilsky EJ
    J Pharmacol Exp Ther; 2011 Mar; 336(3):767-78. PubMed ID: 21118955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifunctional Peptidomimetic G Protein-Biased Mu-Opioid Receptor Agonist and Neuropeptide FF Receptor Antagonist KGFF09 Shows Efficacy in Visceral Pain without Rewarding Effects after Subcutaneous Administration in Mice.
    Dumitrascuta M; Martin C; Ballet S; Spetea M
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X; Geller EB; Adler MW
    Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide.
    Li Y; Eans SO; Ganno-Sherwood M; Eliasof A; Houghten RA; McLaughlin JP
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
    Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
    Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
    Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
    J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.
    Baumann MH; Majumdar S; Le Rouzic V; Hunkele A; Uprety R; Huang XP; Xu J; Roth BL; Pan YX; Pasternak GW
    Neuropharmacology; 2018 May; 134(Pt A):101-107. PubMed ID: 28807672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
    Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
    J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.
    Toll L; Khroyan TV; Polgar WE; Jiang F; Olsen C; Zaveri NT
    J Pharmacol Exp Ther; 2009 Dec; 331(3):954-64. PubMed ID: 19773529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal action of dermorphin, an extremely potent opioid peptide from frog skin.
    Stevens CW; Yaksh TL
    Brain Res; 1986 Oct; 385(2):300-4. PubMed ID: 2877713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.